Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKore Potash Regulatory News (KP2)

Share Price Information for Kore Potash (KP2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: -0.45 (-20.93%)
Spread: 0.20 (12.50%)
Open: 2.10
High: 1.90
Low: 1.68
Prev. Close: 2.15
KP2 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Expiry of Unlisted Options

22 Sep 2020 13:00

RNS Number : 7506Z
Kore Potash PLC
22 September 2020
 

22 September 2020

 

Kore Potash Plc

("Kore Potash" or the "Company")

 

Expiry of Unlisted Options and Change in Director's Interest Notice

 

The Company wishes to advise that 4,000,000 unlisted options exercisable at £0.11 each expired unexercised on 27 June 2020.

 

Included is a copy of a change in director's interest notice for Mr Hathorn, the Company's Chairman, who held these unlisted options.

 

The Company notes the lodgement of the above is outside the time prescribed by the ASX listing rules. The late lodgement was due to an administrative oversight. The Company and Mr Hathorn is aware of the requirements under ASX Listing Rules 3.19A and 3.19B. The administrative oversight has not affected the Company's current arrangement for ensuring timely notification in accordance with the listing rules.

 

The below change in director's interest notice also reflects the issue of 58,719,906 fully paid ordinary shares to Mr Hathorn following shareholder approval at the Company's recently held General Meeting.

 

ENDS

 

For further information, please visit www.korepotash.com or contact:

 

Kore Potash

Brad Sampson - CEO

 

Tel: +27 11 469 9140

Tavistock Communications

Jos Simson

Edward Lee

 

Tel: +44 (0) 20 7920 3150

Canaccord Genuity - Nomad and Broker

James Asensio

Henry Fitzgerald-O'Connor

 

Tel: +44 (0) 20 7523 4600

Shore Capital - Joint Broker

Jerry Keen

Toby Gibbs

Mark Percy

Tel: +44 (0) 20 7408 4050

 

 

Rule 3.19A.2

Appendix 3Y

 

Change of Director's Interest Notice

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

 

Name of Entity

Kore Potash Plc (ASX, AIM, JSE : KP2)

ARBN

621 843 614

 

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director

David Andrew Hathorn

Date of Last Notice

7 April 2020

 

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

 

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Direct or indirect interest

Direct and Indirect

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

Theseus (Guernsey) Limited as Trustee of the Belle Terre Trust (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Stapleford Trust (A Trust that the Director is a beneficiary of)

Date of change

21 September 2020

No. of securities held prior to change

 

54,457,146 Fully Paid Ordinary Shares (AIM Listed)

 

 

 

250,000 Equity Warrants exercisable at AUD 0.30 each expiring on 29 March 2021

 

 

500,000 Performance Rights each expiring 22 May 2022

 

4,000,000 Unlisted Options exercisable at £0.11 each expiring on 27 June 2020

Held in the name of

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Direct

 

 

Direct

Class

Unlisted Options and Fully Paid Ordinary Shares (AIM)

Number acquired

58,719,906 Fully Paid Ordinary Shares (AIM)

Number disposed

4,000,000 Unlisted Options exercisable at £0.11 each expiring on 27 June 2020 (expired unexercised)

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

£0.0065 per Share

No. of securities held after change

 

54,457,146 Fully Paid Ordinary Shares (AIM Listed)

 

 

 

250,000 Equity Warrants exercisable at AUD 0.30 each expiring on 29 March 2021

 

 

 

29,359,953 Fully Paid Ordinary Shares (AIM Listed)

 

 

29,359,953 Fully Paid Ordinary Shares (AIM Listed)

 

 

 

 

500,000 Performance Rights each expiring 22 May 2022

Held in the name of

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Barland Trust - Barland Trust Portfolio B (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Belle Terre Trust (A Trust that the Director is a beneficiary of)

 

Theseus (Guernsey) Limited as Trustee of the Stapleford Trust (A Trust that the Director is a beneficiary of)

 

Direct

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

(i) Participation in Placement as approved at the Company's General Meeting on 18 September 2020 (refer to Resolution 3)

(ii) Expiry of Unlisted Options

 

Part 2 - Change of director's interests in contracts

 

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

 

Detail of contract

N/A

Nature of interest

N/A

Name of registered holder

(if issued securities)

N/A

Date of change

N/A

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

N/A

Interest acquired

N/A

Interest disposed

N/A

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

N/A

Interest after change

N/A

 

Part 3 - +Closed period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?

No

If so, was prior written clearance provided to allow the trade to proceed during this period?

N/A

If prior written clearance was provided, on what date was this provided?

N/A

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKKBBNDBKDFCB
Date   Source Headline
30th Jan 20192:05 pmRNSSecond Price Monitoring Extn
30th Jan 20192:00 pmRNSPrice Monitoring Extension
29th Jan 20197:00 amRNSKola Definitive Feasibility Study
8th Jan 20197:00 amRNSCDI Monthly Movement
7th Dec 20188:50 amRNSMining Convention passed into Law
5th Dec 20187:00 amRNSCDI Monthly Movement
21st Nov 20187:00 amRNSExtensions to Sylvinite Deposits Expected
16th Nov 201811:06 amRNSSecond Price Monitoring Extn
16th Nov 201811:00 amRNSPrice Monitoring Extension
5th Nov 20189:00 amRNSCDI Monthly Movement
1st Nov 20187:00 amRNSDefinitive Feasibility Study ("DFS") Received
30th Oct 20189:01 amRNSCashflow Report for Q3 2018
30th Oct 20189:00 amRNSReview of Operations for Q3 2018
5th Oct 20189:00 amRNSCDI Monthly Movement
1st Oct 20187:00 amRNSCompany Secretary Change
28th Sep 20187:15 amRNSDefinitive Feasibility Study Update
12th Sep 201810:15 amRNSFINANCIAL REPORT FOR HALF YEAR ENDED 30 JUNE 2018
12th Sep 20187:00 amRNSDedicated Offshore Transhipment Area Licenced
10th Sep 20189:00 amRNSCDI Monthly Movement
28th Aug 20188:30 amRNSApproval of ESIA for Dougou licence area
20th Aug 201810:00 amRNSMaiden Sylvinite MRE at Dougou Extension
7th Aug 20183:23 pmRNSDirector/PDMR Shareholding - Replacement
7th Aug 20189:32 amRNSCDI Monthly Movement
7th Aug 20189:31 amRNSDirector / PDMR Shareholdings
7th Aug 20189:30 amRNSDirector / PDMR Shareholding
2nd Aug 20187:02 amRNSDirector Interest Notice
2nd Aug 20187:01 amRNSAppendix 3B
2nd Aug 20187:00 amRNSDirector Interest Notices
31st Jul 20187:01 amRNSReview of Operations for Q2 2018
31st Jul 20187:00 amRNSCashflow Report for Q2 2018
18th Jul 20189:30 amRNSCDI Monthly Movement
27th Jun 201811:01 amRNSResults of AGM
27th Jun 201811:00 amRNSExpiry of unlisted options
12th Jun 20188:45 amRNSCDI Monthly Movement
1st Jun 20188:00 amRNSAnnual Financial Report
30th May 20187:00 amRNSAppointment of CEO
23rd May 20187:00 amRNSAppointment of a Non-Executive Director
4th May 20188:00 amRNSCDI Monthly Movement
30th Apr 20189:31 amRNSReview of Operations for Q1 2018
30th Apr 20189:30 amRNSCashflow Report for Q1 2018
26th Apr 20183:40 pmRNSAdmission Document Disclosures
26th Apr 20183:37 pmRNSHolding(s) in Company
26th Apr 20181:30 pmRNSDirector Resignation
18th Apr 201810:00 amRNSExpiry of Unlisted Options
17th Apr 20189:30 amRNSDirector/PDMR Shareholding
13th Apr 20189:00 amRNSDirector/PDMR Shareholding
10th Apr 20188:00 amRNSASX waiver in relation to quotation of CDIs
9th Apr 201810:20 amRNSDirector/PDMR Shareholding
5th Apr 20181:09 pmRNSDirector/PDMR Shareholding
4th Apr 20181:55 pmRNSNotice under Section 708A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.